Uoa Real Estate Investment (KLSE:UOAREIT)

Ligand Pharmaceuticals Balance Sheet

Financials in millions MYR. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Property, Plant & Equipment	1,740	1,742	1,720	1,717	1,717	1,739
Cash & Equivalents	5.09	4.86	4.3	3.91	7.15	5.41
Accounts Receivable	3.08	3.55	5.06	2.03	3.41	2.53
Other Receivables	9.52	6.14	4.23	2.56	2.42	2.63
Other Current Assets	0.7	4.06	4.29	3.43	3.14	14.75
Total Assets	1,758	1,760	1,738	1,729	1,733	1,764
Accrued Expenses	-	4.15	3.74	2.98	2.53	3.21
Current Income Taxes Payable	0.04	0	0.03	0.02	0	0.02
Current Unearned Revenue	-	1.44	1.93	1.43	1.52	0.43
Other Current Liabilities	-	35.08	34.11	22	17.32	40.48
Long-Term Deferred Tax Liabilities	17.67	17.67	19.64	21.19	21.19	23.38
Other Long-Term Liabilities	43.76	-	-	10.43	13.92	12
Total Liabilities	775.57	776.84	744.15	733.44	739.68	783.54
Common Stock	750.56	750.56	750.56	750.56	750.56	750.75
Retained Earnings	231.79	232.83	243.02	245.11	242.47	229.55
Shareholders' Equity	982.34	983.38	993.57	995.66	993.03	980.3
Total Liabilities & Equity	1,758	1,760	1,738	1,729	1,733	1,764
Total Debt	714.1	718.5	684.7	675.4	683.2	704.02
Net Cash (Debt)	-709.01	-713.64	-680.4	-671.49	-676.05	-698.61
Net Cash Per Share	-1.05	-1.06	-1.01	-0.99	-1.00	-1.64
Filing Date Shares Outstanding	675.6	675.6	675.6	675.6	675.6	675.6
Total Common Shares Outstanding	675.6	675.6	675.6	675.6	675.6	675.6
Book Value Per Share	1.45	1.46	1.47	1.47	1.47	1.45
Tangible Book Value	982.34	983.38	993.57	995.66	993.03	980.3
Tangible Book Value Per Share	1.45	1.46	1.47	1.47	1.47	1.45

Updated Jan 21, 2025. Source: S&P Global Market Intelligence. Real Estate template. Financial Sources.